C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
12/2002
12/05/2002	US20020183321 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/03/2002	US6489343 Tetrahydropyran derivatives and their use as therapeutic agents
11/2002
11/28/2002	WO2002094804A1 A process for lactonization to produce simvastatin
11/28/2002	WO2002094803A1 A process for lactonization to produce highly pure simvastatin
11/28/2002	WO2002094767A2 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002	US20020177594 Inhibitors of histone deacetylase
11/28/2002	CA2447671A1 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/27/2002	EP1259502A2 Biologically active analogs of discodermolide
11/27/2002	EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002	EP0777492A4 Combinatorial libraries of substrate-bound cyclic organic compounds
11/26/2002	US6486343 Substituted phenyl keto enols as pesticides and herbicides
11/26/2002	US6486342 Substituted chiral allosteric hemoglobin modifiers
11/26/2002	US6486320 Preparation of camptothecin and of its derivatives
11/26/2002	US6486184 1-(cyclopentyloxy-(3,4-dichloro- phenyl)-acetyl)-3-methyl-urea for example; use in treating hyperglycemia characteristic of all type ii diabetes
11/26/2002	CA2051855C Process for producing n-substituted-1-deoxynojirimycin
11/21/2002	WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	WO2002092555A1 Sialic acid derivatives
11/21/2002	US20020173665 Use treating pain, urinary incontinence and bladder overactivity
11/21/2002	US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002	US20020173631 4-((5,5-dimethyl-5,6,7,8-tetrahydro-8-hydroxynaphthalen-2 -yl)carbonyloxy)benzoic acid, benzyl ester for example; receptor subtype selectivity for side effect reduction
11/21/2002	US20020173541 Arthropod-controlling composition
11/21/2002	DE10108471C1 Kontinuierliches Verfahren zur Herstellung von 5,6-Dihydro-4-hydroxy-2-pyronen A continuous process for the preparation of 5,6-dihydro-4-hydroxy-2-pyrones
11/21/2002	CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/19/2002	US6482986 Benzene derivatives, preparation method and pharmaceutical compositions containing same
11/19/2002	US6482950 Squarylium compounds, and processes and intermediates for the synthesis of these compounds
11/19/2002	CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/14/2002	WO2002089810A1 Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
11/14/2002	WO2002064550A8 Glucocorticoid receptor modulators
11/13/2002	EP1256342A1 Hypoglycemics comprising organic zinc (ii) complexes
11/13/2002	EP1255747A2 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
11/13/2002	EP1255729A1 Preparation of nitrogen mustard derivatives
11/12/2002	US6479682 Compounds having protected hydroxy groups
11/12/2002	US6479673 Antiretroviral enantiomeric nucleotide analogs
11/12/2002	US6479538 Cyclic ether vitamin D3 compounds, 1α(OH)3-EPI-vitamin D3 compounds and uses thereof
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479489 Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/12/2002	US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002	WO2002088106A2 Cysteine protease inhibitors
11/07/2002	WO2001036365A3 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
11/07/2002	US20020165269 Process for preparing optically active dihydropyrones
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165096 Applying to weeds
11/07/2002	US20020164498 Novel compound for red organic electroluminescent elements and devices
11/07/2002	CA2429001A1 Cysteine protease inhibitors
11/06/2002	EP1254902A1 Agents correcting gene expression regulatory error
11/06/2002	EP1254884A2 Preparation of vinyl ethers from alcohols and alkenes
11/06/2002	EP1161437B1 Phosphabenzene compounds and their use as ligands for hydroformylation catalysts
11/06/2002	EP1064275B1 Process for producing simvastatin and/or its derivatives
11/06/2002	CN1378548A Method for separating analogous organic compounds
11/06/2002	CN1377577A Composition for controlling tardigvada
11/05/2002	WO2001085673A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476229 Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
11/05/2002	US6476067 N-formyl hydroxylamine derivatives as antibacterial agents
11/05/2002	CA2408209A1 Phenyl-substituted 2-enamino-keto nitriles
10/2002
10/31/2002	WO2002030415A9 Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
10/31/2002	US20020161265 To ketones and aldehydes, by reacting with alkali hypohalite under alkaline conditions, using selective heterogeneous oxidation catalyst insoluble in the reaction medium that has 4-oxy-2,2,6,6-tetramethylpiperidin-1-oxyl groups
10/31/2002	US20020161037 Continuous process for preparing dihydropyrones
10/31/2002	US20020161034 Spiro-pyran compounds; use as pesticides and herbicides
10/31/2002	US20020159973 Administering to the patient at least one statin (HMG-Coa-reductase inhibitor) in an amount effective to modulate MHC class II (Major Histocompability complex) or CD/40(antigen) expression in the patient
10/31/2002	US20020157939 Subjecting a polyhydric alcohol compound having protected hydroxy group(s) to microwave irradiation in presence of basic compound or acid to deprotect the protecting groups of hydroxy group of polyhydric alcohol compound
10/30/2002	EP1253138A2 Novel tertiary amine compounds having an ester structure and processes for preparing same
10/30/2002	EP1252138A2 A new process for the preparation of latanoprost
10/30/2002	EP1252133A2 Pharmaceutical compounds
10/30/2002	EP1000172A4 Detection of targets with green fluorescent protein and fluorescent variants thereof
10/30/2002	CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002	CN1093536C 5-lipoxygenase inhibitor
10/29/2002	US6472542 Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin
10/29/2002	US6472532 Inexpensive method using kojic acid as safe starting material for synthesis of orally active iron chelators
10/29/2002	US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
10/29/2002	CA2210492C Neuraminic acid derivatives, their preparation and their medical use
10/24/2002	WO2002083659A1 Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083066A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002	US20020156298 Reacting dihydroxycarboxylic acid with mineral acid; stirring; crystallization
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	US20020155426 Prevention and treatment of amyloid-associated disorders
10/24/2002	CA2444481A1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/23/2002	WO2001081331A1 Hydrates and crystals of a neuraminic acid compound
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1250047A2 Herbicidal composition
10/23/2002	EP1161427B1 Improved process for asymmetric hydrogenation
10/23/2002	CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002	CN1093125C Sulfamide-metalloprotease inhibitors
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469048 Bactericides; anticancer agents
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/16/2002	EP1248761A1 Compounds which mimic the chemical and biological properties of discodermolide
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	CN1374946A Substituted aromatic-ring compounds, process for producing the same, and us
10/15/2002	US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002	US6465511 Treatment of septic shock

1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 129